SRM Equity Partners Announces Sale of Rezolut
January 6, 2026 – Austin, TX – SRM Equity Partners (“SRM”) announced today that it has sold its portfolio company Rezolut to Envision Radiology (“Envision”), a leading national provider of outpatient imaging services. The transaction closed on December 31, 2025.
Rezolut is a scaled provider of outpatient imaging services with a focus on women’s imaging. Rezolut owns, operates, and manages 42 full-modality outpatient imaging centers in Arizona, California, New Jersey, New Mexico, New York, and Pennsylvania. Rezolut also provides mobile women’s imaging services, in-house women’s imaging services, and imaging equipment sales and service.
SRM is a private equity firm focused on the lower middle market with offices in Atlanta, Georgia and Austin, Texas. SRM employs a buy-and-build strategy across its portfolio, and invests thematically in sectors such as business services, industrial services, manufacturing, and healthcare services.
Dr. Jin Kim, CEO of Rezolut, said, “Envision is the perfect partner for Rezolut as they share our commitment to patients. Together, we want to build and incorporate the next generation of innovative solutions that provide the highest level of care. For Rezolut teammates, we are thrilled to become part of a 100% employee-owned company.”
Jeremiah Yu, Managing Partner of SRM, said, “We are thrilled to have found a home for Rezolut within a company that shares its core beliefs and values. SRM is confident that Rezolut’s strong growth trajectory will continue under Envision’s stewardship, and we extend our best wishes to Envision as it embarks on this new journey.”
SRM’s transaction team consisted of Jeremiah Yu, John Cote, Beau Brace, and Matt Greenway.
J.P. Morgan served as financial advisor and McGuireWoods LLP served as legal counsel to Rezolut. Stout Capital, LLC acted as the exclusive financial advisor for the acquisition and was the sole placement agent for the financing of Envision. Bryan Cave Leighton Paisner LLP served as legal counsel to Envision. Terms of the transaction were not disclosed.